These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11074472)

  • 1. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients.
    Clarke JR; Galpin S; Braganza R; Ashraf A; Russell R; Churchill DR; Weber JN; McClure MO
    J Med Virol; 2000 Dec; 62(4):445-9. PubMed ID: 11074472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.
    Chew CB; Herring BL; Zheng F; Browne C; Saksena NK; Cunningham AL; Dwyer DE
    J Clin Virol; 1999 Oct; 14(2):87-94. PubMed ID: 10588451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T; Charlebois E; Nassos P; Kahn J; Hecht FM; Yajko D; Ng V; Hadley K
    J Clin Microbiol; 2000 Mar; 38(3):1113-20. PubMed ID: 10699005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina.
    Hodara V; Monticelli A; Pampuro S; Salomón H; Jauregui Rueda H; Libonatti O
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):107-13. PubMed ID: 9695883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of human immunodeficiency virus viral load testing in Australia.
    Best SJ; Gust AP; Johnson EI; McGavin CH; Dax EM
    J Clin Microbiol; 2000 Nov; 38(11):4015-20. PubMed ID: 11060062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplicor HIV monitor, NASBA HIV-1 RNA QT and quantiplex HIV RNA version 2.0 viral load assays: a Canadian evaluation.
    Prud'homme IT; Kim JE; Pilon RG; Minkus T; Hawley-Foss N; Cameron W; Rud EW
    J Clin Virol; 1998 Dec; 11(3):189-202. PubMed ID: 9949955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two commercial procedures for quantification of human immunodeficiency virus type 1 RNA with respect to HIV-1 viral subtype and antiviral treatment.
    Schmid I; Arrer E; Hawranek T; Patsch W
    Clin Lab; 2000; 46(7-8):355-60. PubMed ID: 10934582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
    Holguín A; de Mendoza C; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):256-9. PubMed ID: 10385013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
    Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
    J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.
    Pasquier C; Sandres K; Salama G; Puel J; Izopet J
    J Virol Methods; 1999 Aug; 81(1-2):123-9. PubMed ID: 10488770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG; Côté L; Fauvel M; René P; Vincelette J
    J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.
    Emery S; Bodrug S; Richardson BA; Giachetti C; Bott MA; Panteleeff D; Jagodzinski LL; Michael NL; Nduati R; Bwayo J; Kreiss JK; Overbaugh J
    J Clin Microbiol; 2000 Jul; 38(7):2688-95. PubMed ID: 10878065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.
    Swanson P; Soriano V; Devare SG; Hackett J
    J Clin Microbiol; 2001 Mar; 39(3):862-70. PubMed ID: 11230396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HIV-1 genetic diversity in China on the measurement of viral load.
    Wang Y; Song A; Xu S; Li X; Chong H; Zhao C; Nie J; Zhang C
    J Med Virol; 2008 Jan; 80(1):1-8. PubMed ID: 18041045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy.
    Segondy M; Izopet J; Pellegrin I; Montes B; Dumon B; Pasquier C; Peeters M; Fleury HJ; Puel J; Reynes J
    J Clin Microbiol; 1998 Nov; 36(11):3392-5. PubMed ID: 9774604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.
    Antunes R; Figueiredo S; Bártolo I; Pinheiro M; Rosado L; Soares I; Lourenço H; Taveira N
    J Clin Microbiol; 2003 Jul; 41(7):3361-7. PubMed ID: 12843094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
    J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels.
    Aschbacher R; Monari P; Lolli S; Donzelli C; Colangeli V; Vignoli M; Ramazzotti E; Furlini G; Re MC
    New Microbiol; 1999 Jan; 22(1):1-9. PubMed ID: 10190111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.
    Elbeik T; Alvord WG; Trichavaroj R; de Souza M; Dewar R; Brown A; Chernoff D; Michael NL; Nassos P; Hadley K; Ng VL
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):330-9. PubMed ID: 11917236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.